Apotea AB (publ) (CHIX:APOTES) 6-Month Price Index: 1.34 (As of Sep. 11, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CHIX:APOTES Apotea AB (publ) CHIX:APOTES
16 GF Score
Price kr76.83
! 1 Warning Sign
View Full Analysis

What is Apotea AB (publ) 6-Month Price Index?

Apotea AB (publ) CHIX:APOTES 16 6-Month Price Index is 1.34 as of Sep. 11, 2026. GuruFocus rates CHIX:APOTES with a GF Score™ of 16/100. The stock has 1 warning sign investors should review.

6-Month Price Index is an intermediate-term momentum that shows the price change relative to 6-month ago. It’s calculated by current share price divided by share price 6-months ago. As of today (2026-09-11), Apotea AB (publ)'s 6-Month Price Index is 1.34.

Apotea AB (publ)  (CHIX:APOTEs) 6-Month Price Index Explanation

Price Index (PI) also called momentum. Strategies involving Price Index are also known as momentum strategies as they allow investors to profit from a company’s stock price. 6-Month Price Index is an intermediate-term momentum that shows the price change relative to 6-month ago.

The investment strategy for momentum investors is to buy winners and sell losers. That is, buy stocks that performed well and sell stocks that performed poorly in the past.

Apotea AB (publ) 6-Month Price Index Related Terms

Apotea AB (publ) 6-Month Price Index Competitor Comparison

For the Pharmaceutical Retailers subindustry, Apotea AB (publ)'s 6-Month Price Index, along with its competitors' market caps and 6-Month Price Index data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CHIX:APOTES
16GF Score
Apotea AB (publ) CHIX:APOTES
6-Month Price Index is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Apotea AB (publ)  (CHIX:APOTEs) 6-Month Price Index Calculation

6-Month Price Index is calculated as following:

6-Month Price Index=Current Share Price / Share Price 6-Months Ago

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about 6-Month Price Index →
What does a 6-Month Price Index of 1.34 mean?
Apotea AB (publ) (CHIX:APOTES) has a 6-Month Price Index of 1.34 as of Sep. 11, 2026. 6-Month Price Index is an intermediate-term momentum that shows the price change relative to 6-month ago. View historical data on Apotea AB (publ) and its competitors.
Is Apotea AB (publ)'s 6-Month Price Index too high?
Apotea AB (publ)'s current 6-Month Price Index is 1.34. Overall, Apotea AB (publ) has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.
How does Apotea AB (publ)'s 6-Month Price Index compare to competitors?
Apotea AB (publ)'s 6-Month Price Index of 1.34 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 6-Month Price Index for a Healthcare Providers & Services company?
A good 6-Month Price Index depends on the Healthcare Providers & Services industry context. However, 6-Month Price Index should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 6-Month Price Index mean?
A high 6-Month Price Index can signal that a stock is expensive relative to its fundamentals. 6-Month Price Index is an intermediate-term momentum that shows the price change relative to 6-month ago. View historical data on Apotea AB (publ) and its competitors. Apotea AB (publ)'s current 6-Month Price Index is 1.34. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Apotea AB (publ) stock overvalued right now?
Apotea AB (publ) (CHIX:APOTES) has a current 6-Month Price Index of 1.34. The current 6-Month Price Index is 1.34. Apotea AB (publ)'s overall GF Score™ is 16/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 6-Month Price Index calculated?
6-Month Price Index is calculated from a company's financial statements. For Apotea AB (publ) (CHIX:APOTES), the current 6-Month Price Index is 1.34 as of Sep. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Apotea AB (publ) Business Description

Other Exchanges APOTEA:SwedenV30:Germany
Address Sveavagen 168, Stockholm, SWE, 11346
Apotea AB (publ) is engaged in the online pharmacy with fast deliveries, good prices and a large selection. Its vision is to be tomorrow's pharmacy by constantly facilitating and simplifying for the customer.
16GF Score

Get the complete analysis for CHIX:APOTES

6-Month Price Index is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr76.83
Price